Myofibroblasts enable invasion of endothelial cells into three-dimensional tumor cell clusters: a novel in vitro tumor model Jennifer Walter-YohrlingBruce M. PrattBeverly A. Teicher Original Article 17 July 2003 Pages: 263 - 269
Targeting of a novel fusion protein containing methioninase to the urokinase receptor to inhibit breast cancer cell migration and proliferation Karine PeronTara N. JonesJ. Thomas Pento Original Article 25 June 2003 Pages: 270 - 276
A phase I study of ZD0473 combined with paclitaxel for the treatment of solid malignancies Chris TwelvesMartin ReckStan Kaye Original Article 25 June 2003 Pages: 277 - 281
Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen Marc YchouJacqueline DuffourFrédéric Pinguet Original Article 19 June 2003 Pages: 282 - 290
Selective enhancement of ifosfamide-induced toxicity in Chinese hamster ovary cells Sonali M. SmithSusan M. LudemanM. Eileen Dolan Original Article 04 July 2003 Pages: 291 - 302
Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer Robert I. HaddadDavid A. Van Echo Original Article 25 June 2003 Pages: 303 - 306
Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines Ioannis A. AvramisWalter E. LaugVassilios I. Avramis Original Article 25 June 2003 Pages: 307 - 318
Effect of Wf-536, a novel ROCK inhibitor, against metastasis of B16 melanoma Masahide NakajimaKazutaka HayashiTakao Kondo Original Article 29 May 2003 Pages: 319 - 324
The role of DNA synthesis inhibition in the cytotoxicity of 2′,2′-difluoro-2′-deoxycytidine Leo J. OstruszkaDonna S. Shewach Original Article 17 June 2003 Pages: 325 - 332
A phase I study of 9-aminocamptothecin as a colloidal dispersion formulation given as a fortnightly 72-h infusion Jorge LeguizamoMary QuinnJean L. Grem Original Article 18 June 2003 Pages: 333 - 338
A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer Juan José ReinaJorge AparicioJosé Andrés Moreno-Nogueira Original Article 08 July 2003 Pages: 339 - 345
Equivalent single-dose pharmacokinetics of two different dosing methods of prolonged-release fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancer John F. R. RobertsonM. P. Harrison Short Communication 19 July 2003 Pages: 346 - 348
